We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA CITES CYBERONICS FOR RESPONSES TO cGMP ISSUES
FDA CITES CYBERONICS FOR RESPONSES TO cGMP ISSUES
January 6, 2005
Houston-based Cyberonics confirmed it has received a warning letter from the FDA that asserted the company’s responses to issues involving current good manufacturing practices (cGMPs) at its manufacturing facility have been insufficient.